Lenacapavir: WHO Recommends New Drug to Prevent HIV
Lenacapavir, a long-acting injectable drug for HIV prevention, now receives support from the WHO. MEXICO CITY (apro).— The World Health Organization (WHO) has recommended the use of Lenacapavir, a long-acting injectable antiretroviral drug, as an additional option for the prevention of the Human Immunodeficiency Virus (HIV). This endorsement was announced on July 14, 2025, at … Read more



